TrialArthritis research & therapy2018

A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy.

Stanley B Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.